Product
EN3267
1 clinical trial
2 indications
Indication
PainIndication
CancerClinical trial
A Multiple-Dose, Non-Randomized, Open-Label, Multicenter Study to Evaluate the Long-Term Safety and Effectiveness of EN3267 in the Treatment of Breakthrough Pain in Cancer PatientsStatus: Completed, Estimated PCD: 2008-12-01